Design and analytic validation of BCR-ABL1 quantitative reverse transcription polymerase chain reaction assay for monitoring minimal residual disease

Lawrence J. Jennings, Frederick A. Smith, Kevin C. Halling, Diane L. Persons, Suzanne Kamel-Reid

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Design and analytic validation of BCR-ABL1 quantitative reverse transcription polymerase chain reaction assay for monitoring minimal residual disease'. Together they form a unique fingerprint.

Medicine & Life Sciences